Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:14 AM
Ignite Modification Date:
2025-12-25 @ 3:14 AM
NCT ID:
NCT00808405
Eligibility Criteria:
Inclusion Criteria:
* HIV negative as determined by concordant rapid testing
* HSV-2 seropositive (Focus HerpeSelect \>3.4)
* At least one prior occurrence of GUD
* 18-50 years of age
Exclusion Criteria:
* Current use, or use w/in past 7 days of acyclovir, valacyclovir, or famciclovir
* Prior hypersensitivity \&/or allergic reaction to acyclovir
* Use of probenicid
* Current use, or use within past 28 days, of an investigational agent
* Currently pregnant or nursing
* Currently plan to become pregnant during next 3 months
* Any condition that will interfere with successful completion of study procedures
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT00808405
Study Brief:
Protocol Section:
NCT00808405